丽珠医药(01513)：704.5万份股票期权将于 2024 年 1 月 2 日开始可以行权
丽珠医药(01513)公布，公司 2022 年股票期权激励计划首次授予第一个行权期的行权条件已经成就，同意符合行权条件的 1,001名激励对象在第一个行权期可行权704.5万份股票期权，行权价格为31.31 元/A 股。经深圳证券交易所及中国证券登记结算有限责任公司深圳分公司(简称“登记公司”)审核，有关期权将于 2024 年 1 月 2 日开始可以行权。本次可以行权的期权简称：丽珠 JLC3，期权代码：037312。
Reprinted from 引领外汇网，the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.